Daniel David Federman, (1928 – September 6, 2017)[1] was an American endocrinologist and the Carl W. Walter Distinguished Professor of Medicine and the dean for medical education at Harvard Medical School. He helped change medical education at through its New Pathway curriculum around the early 1990s, and his work helped create the field of genetic endocrinology.[2][3] Federman also worked for over thirty years at Boston's Brigham and Women's Hospital, a Harvard Medical School teaching hospital in the Longwood Medical and Academic Area.[4][5][6][7]
Federman was born in New York City in 1928, the son of European immigrants who settled in the Bronx.[11] He graduated summa cum laude from Harvard College in 1949 and magna cum laude from Harvard Medical School in 1953.
He returned to Harvard Medical School and Massachusetts General Hospital in 1964, serving as chief of endocrinology. He continued as assistant chief of medical services in 1967, associate professor of medicine in 1970, and associate chairman of medicine in 1971. In 1973, Federman was recruited to become physician-in-chief and chair of the Department of Medicine at Stanford University.
From 2000 to 2007, Federman was senior dean for alumni relations and clinical teaching at Harvard Medical School. After retiring in 2007, he taught at the University of Miami's Miller School of Medicine.[9]
Personal life
As a medical student at Massachusetts General Hospital in Boston, Federman met his wife Elizabeth (Betty) Buckley.[12] They had two daughters, one of whom graduated from Harvard Medical School while he was serving as Harvard Medical School's dean of medical education.
Daniel D. Federman Staff Award for Exceptional Service to HMS/HSDM[13]
The White House Commission on Complementary and Alternative Medicine Policy
Named Chair, Daniel D. Federman, MD Professor in Residence of Global Health and Social Medicine and Medical Education, currently held by Edward M. Hundert, MD, also current Dean for Medical Education at Harvard Medical School[14]
Chair of the Advisory Board, Scholars in Clinical Science Program, Harvard Medical School
He authored at least 67 works in 207 publications in four languages and 7,370 library holdings[15] and continued publishing in refereed journals until at least 2011.
^"Our Advisory Committee". Benchmarking the Comparative Effectiveness of Diabetes Treatments Using Patient-Reported Outcomes and Socio-Demographic Factors. February 16, 2016.
